Related Experiment Video

Updated: Aug 15, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

[Multiple sclerosis: molecular and cellular mechanisms]

A N Boĭko, O O Favorova

    Molekuliarnaia Biologiia
    |July 1, 1995
    PubMed

    Insights

    Multiple sclerosis (MS) is a chronic central nervous system disease involving myelin damage. Genetic factors, particularly HLA class II genes, and environmental influences contribute to MS pathogenesis, though the exact cause remains unknown.

    Area of Science:

    • Neuroimmunology
    • Genetics
    • Pathogenesis of Multiple Sclerosis

    Context:

    • Multiple sclerosis (MS) is a chronic, debilitating central nervous system disease.
    • Pathogenesis involves immune-mediated inflammation and demyelination.
    • Etiology is multifactorial, involving genetic predisposition and environmental factors.

    Purpose:

    • To explore the complex interplay of genetic and environmental factors in MS pathogenesis.
    • To investigate the role of immune system components, including T-cells and B-cells, in myelin damage.
    • To identify key genetic associations, such as Human Leukocyte Antigen (HLA) genes, in MS susceptibility.

    Summary:

    • MS pathogenesis is characterized by demyelination, with immunomediated inflammation playing a key role.
    • Both genetic predisposition (especially HLA class II alleles like DRB1*1501) and environmental factors contribute to MS.
    • While specific infectious agents or environmental factors are not confirmed causes, their correlation with MS is noted.

    Impact:

    • Understanding genetic and molecular mechanisms can lead to novel therapeutic strategies for MS.
    • Identifying susceptibility genes aids in risk assessment and potential prevention approaches.
    • Further research into MS pathogenesis may uncover new targets for treating this chronic neurological condition.

    More Related Videos

    Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord10:44

    Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

    Published on: February 22, 2015

    Comprehensive Autopsy Program for Individuals with Multiple Sclerosis09:41

    Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

    Published on: July 19, 2019

    Related Concept Videos

    Parkinson's Disease: Overview01:15

    Parkinson's Disease: Overview

    Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
    T Cell Types and Functions01:24

    T Cell Types and Functions

    When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
    Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
    Multiple Sclerosis l: Introduction01:19

    Multiple Sclerosis l: Introduction

    Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
    Parkinson Disease ll: Pathophysiology01:24

    Parkinson Disease ll: Pathophysiology

    Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
    Myasthenia Gravis ll: Pathophysiology01:22

    Myasthenia Gravis ll: Pathophysiology

    The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
    Secondary Spinal Cord Injury llI: Pathophysiology01:25

    Secondary Spinal Cord Injury llI: Pathophysiology

    Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...